Shruti Haasan is a Daddy's girl and her latest Instagram post can vouch for that. On Tuesday, Shruti posted two adorable images with her father Kamal Haasan. In the pictures, Kamal Haasan is seen ...

Actress Shruti Haasan has begun dubbing for her role in the much-anticipated action film Coolie, directed by Lokesh Kanagaraj. The film, which also stars superstar Rajinikanth, is set for a grand ...

Actor and musician Shruti Haasan has shared a heartwarming throwback, showcasing her first modeling gig. Posing against the ocean breeze in a rich blue ensemble, Shruti's caption read ...

Shruti Haasan recently took fans down memory lane by sharing a throwback image from her very first campaign shoot. Dressed in a breezy blue ensemble with a beachside backdrop, the image captures a ...

NEW YORK, April 23, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company’s common stock ...

Pfizer (NYSE: PFE) has been one of those companies, with danuglipron being a treatment it was hopeful could eventually come to market as a once-daily pill. Unfortunately, those hopes recently came ...

Shruti Pandey, ahead of 'Raid 2' release, revealed she thankfully avoided the casting couch but faced uncomfortable early career conversations. She highlighted social media's impact, noting its ...

Pharmaceutical and biotechnology company Pfizer marks 70 years of dedication to its mission of advancing patient health in the Philippines, coinciding with its 175th-year global milestone.

Pfizer is ending the development of its GLP-1 weight loss drug, danuglipron. A patient in a clinical trial experienced a liver injury, potentially due to the drug. Pfizer has a massive pipeline ...

BofA cuts Pfizer’s Q1 2025 EPS estimate by 4.9% and revenue by 2.1% due to updated assumptions. Pfizer stock trades at 7x expected 2024 earnings, lower than peer average; dividend yield stands ...

Ratings for Pfizer PFE were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings ...